(Received for publication December 17, 1979) The structure of a new antibiotic BN-227 was determined as I by physico-chemical methods. The X-ray analysis also suggested the structure of I. The structure of antibiotic BN-227-F was determined as H. The antibiotic BN-227-F was prepared by addition of a solution of ferric chloride to antibiotic BN-227.
The production, isolation and characterization of antibiotic BN-227 and BN-227-F have been previously described1).
This paper reports the structure determination of these antibiotics.
Structure of Antibiotic BN-227
The molecular formula of antibiotic BN-227 was established as C7H9NO3 from the results of elemental analysis and mass spectrometry (m/e 155, M+) as reported in the previous papery. The IR spectrum showed the presence of hydroxy group (3470 cm-1) and carbonyl group (1650 cm 1). Fig. 1 shows the mass spectrum of antibiotic BN-227 (I). Important ions were observed at ,n/e 155 (M+), 140 (M'-CH3) and 124 (M+-OCH8). The NMR spectrum of I is shown in Fig. 2 . A singlet at 9.70 ppm was assigned to a hydroxy proton, two doublets at 7.20 ppm and 6.53 ppm were assigned to olefinic protons. Singlets at 3.73 ppm and 2.43 ppm were assigned to methoxy and methyl protons.
The antibiotic BN-227 formed a typical 3: 1 complex with Fe3+ ion as afterwards described. The results suggest that the antibiotic BN-227 is a hydroxamic acid. Many of natural products which contain a hydroxamic acid have been found mainly from microbial sources",". Thus, the structure of antibiotic BN-227 was deduced as I and confirmed by the chemical modification studies summarized in Chart 1. at 4.02 ppm and 3.62 ppm (Fig. 3 ). In the NMR spectrum of tetrahydro derivative (III), on irradiation at 1.32 ppm a multiplet at 4.02 ppm collapsed into a doublet. On irradiation of a multiplet at 4.02 ppm, a doublet of methyl proton at 1.32 ppm collapsed to a singlet.
An examination of the NMR spectrum of the tetrahydro derivative of 1-hydroxy-2-pyridone,
showed that the proton at C5 is at higher field than the proton at C6. Therefore a methyl group is attached to C6. The results of NMR spectrum of antibiotic BN-227 (I) and tetrahydro derivative (III)
are summarized in Table 1 and Table 2 .
X-ray Analysis of Antibiotic BN-227
To confirm the above structure, we carried out an X-ray analysis. The structure was solved by the direct method using the MULTAN7), from which E-map of the most probable set of phases easily revealed the molecular profile. Final refinement of the structure was carried out using the weight W = {C+IF0 +djFo12}-1, where c = 30.0 and d=0.003, and gave an R value of 6.1 %. The results shown in Fig. 7 , coincide with the one expected.
Structure of Antibiotic BN-227-F
The molecular formula of antibiotic BN-227-F was established as C21H24N3O9Fe from the results of elemental analysis, mass spectrometry (m/e 518, M1) and atomic absorption analysis as reported in the previous paper1). The IR spectrum was similar to that of antibiotic BN-227. The NMR spectrum could not be measured, because antibiotic BN-227-F contains iron.
The structure of antibiotic BN-227 (I) and the molecular formula of antibiotic BN-227-F suggested that antibiotic BN-227-F is a chelate compound of three hydroxamates and one ferric ion8,9). In order Fig. 8 shows IR spectra of native antibiotic BN-227-F and synthetic BN-227-F.
On the basis of the evidence already described, the structure of antibiotic BN-227-F should be formulated as II.
Experimental
General methods Melting points were determined with a Yamato MT-1 melting apparatus, and are uncorrected. Specific rotations were determined in a 10 mm cell with a Perkin-Elmer Model 141 polarimeter. IR spectra were obtained with a Hitachi 215 Infrared Spectrophotometer.
UV spectra were recorded with a Hitachi Model 200-20 Spectrophotometer.
NMR spectra were observed with Varian T-60 or XL-100-12 NMR Spectrometer with TMS as the internal standard. Mass spectra were determined with a JEOL JMS-01SG Spectrometer. Preparation of the tetrahydro derivative (III) from I A solution of 1(200 mg) in ethanol (10 ml) was hydrogenated over PtO2 (100 mg) for 2 hours. The reaction mixture was filtered, and the filtrate evaporated to dryness. The residue dissolved in methanol (1.0 ml) and chromatographed on a Sephadex LH-20 column (300 ml). The fractions containing III were collected and evaporated to give a colorless syrup (163 mg).
Anal Preparation of IV from III A solution of III (163 mg) in acetic acid (6 ml) was reduced with zinc powder (400 mg) for 3 days at room temperature. The reaction mixture was filtered, the filtrate was evaporated to dryness. The residue was dissolved in methanol (1 ml) and chromatographed on a Sephadex LH-20 column (300 ml). The fractions containing IV were collected and evaporated to give a colorless syrup (132 mg).
Anal 
